.German TTP-Registry (Thrombotic Thrombocytopenic Purpura) : German TTP- Registry- Prospective Cohort of Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP): Pathophysiology, Diagnosis, Treatment and Follow-Up
1.) Identification of predictive markers for morbidity and mortality in acute TTP and in TTP relapses using a prospective long-term registry and 2.) Investigation of the pathophysiological processes in acute bouts and in remission by recording the clinical symptoms and diagnostics for a better understanding of the course of the disease, optimization of diagnostic procedures and their correlation with the clinical course, recording of therapy response of all therapeutic options in acute bouts, observation of current treatment options to evaluate outcome and prognostic markers and recording of clinical and laboratory chemical data during follow-up to assess long-term morbidity..
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
ClinicalTrials.gov - (2022) vom: 24. Mai Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
610 |
|---|
| Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: May 24, 2022, Last downloaded: ClinicalTrials.gov processed this data on May 30, 2022, Last updated: June 01, 2022 |
|---|
| Study ID: |
NCT05389007 |
|---|---|
| Veröffentlichungen zur Studie: |
|
| fisyears: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
CTG008471347 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG008471347 | ||
| 003 | DE-627 | ||
| 005 | 20230425214503.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220525s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)CTG008471347 | ||
| 035 | |a (UBBS_Klinische_Studien)NCT05389007 | ||
| 035 | |a (UBBS_Klinische_Studien)RGTTP | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a .German TTP-Registry (Thrombotic Thrombocytopenic Purpura) |b German TTP- Registry- Prospective Cohort of Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP): Pathophysiology, Diagnosis, Treatment and Follow-Up |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: May 24, 2022, Last downloaded: ClinicalTrials.gov processed this data on May 30, 2022, Last updated: June 01, 2022 | ||
| 520 | |a 1.) Identification of predictive markers for morbidity and mortality in acute TTP and in TTP relapses using a prospective long-term registry and 2.) Investigation of the pathophysiological processes in acute bouts and in remission by recording the clinical symptoms and diagnostics for a better understanding of the course of the disease, optimization of diagnostic procedures and their correlation with the clinical course, recording of therapy response of all therapeutic options in acute bouts, observation of current treatment options to evaluate outcome and prognostic markers and recording of clinical and laboratory chemical data during follow-up to assess long-term morbidity. | ||
| 650 | 2 | |a Purpura | |
| 650 | 2 | |a Purpura, Thrombocytopenic | |
| 650 | 2 | |a Purpura, Thrombotic Thrombocytopenic | |
| 650 | 4 | |a Medical Condition: Thrombotic Thrombocytopenic Purpura | |
| 650 | 4 | |a Study Type: Observational | |
| 650 | 4 | |a Recruitment Status: Recruiting | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2022) vom: 24. Mai |
| 773 | 1 | 8 | |g year:2022 |g day:24 |g month:05 |
| 856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT05389007 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 24 |c 05 | ||